Analyst firms, including Citigroup and William Blair, have issued ratings and price targets for Dexcom.
1 report, 1 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firms, including Citigroup and William Blair, have issued ratings and price targets for Dexcom.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
-
Citigroup
American investment bank and financial services corporation
-
MarketBeat
American personal finance blog
Related events
- Citigroup raised its price target and gave a buy rating for International Paper, with MarketBeat providing consensus data.
- Citigroup set a neutral rating and reduced price objective for Skyworks Solutions, while Morgan Stanley decreased its target price and set an equal weight rating.
- Citigroup lifted its price target and gave a buy rating for Timken Company, with MarketBeat providing consensus data.
- Financial institutions, including Royal Bank of Canada and Citigroup, raised price objectives and lifted target prices for Crown.
- William Blair reiterated an outperform rating, while Royal Bank of Canada boosted its price objective and Citigroup dropped its price objective for GE Vernova.